Raymond James Financial Services Advisors »

Black Diamond Therapeutics shares owned by Raymond James Financial Services Advisors

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Raymond James Financial Services Advisors from 13F filings

Historical chart of Raymond James Financial Services Advisors investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Raymond James Financial Services Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Raymond James Financial Services Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $132k 30k 4.35
2024-06-30 $80k 17k 4.66
2024-03-31 $87k 17k 5.07

More positions owned by Raymond James Financial Services Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Value Etf (VTV)
Broadcom (AVGO)
Vanguard Index Fds Total Stk Mkt (VTI)
Home Depot (HD)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)

View all positions for Raymond James Financial Services Advisors

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Bellevue Group
Vestal Point Capital
NEA Management Company
BlackRock
BlackRock
Vanguard Group
Ikarian Capital
Tang Capital Management
Siren
Geode Capital Management
ExodusPoint Capital Management
Citadel Advisors
Kennedy Capital Management
Point72 Asset Management

View all funds holding Black Diamond Therapeutics